Mutations in SETD1B were also strongly associated with increased tumor infiltration with CD8+PD-1+TOX+ T cells (Extended Data Fig. 5), highlighting a potential link between this genetic alteration and immune recognition. This evidence concerns the gene TOX and neoplasm.